3Weise A, Prause S, Eidens M, et al. Prevalence of CYP450 gene variations in patients with type 2 ,diabetes[J].Clinical Laboratory, 2010,56(7-8):311-318.
4Mach C M, Chen J H, Mosley S A, et al. Evaluation of liposomal curcumin cytochrome p450 metabolism[J]. Anticancer Research, 2010,30(3):811-814.
5Henkens T, Vanhaecke T, Papeleu P, et al. Rat hepatocyte cultures: conventional monolayer and coculttrres with rat liver epithelial cells [J].Methods in Molecular Biology,2006,320:239-246.
6Vanhaecke T, Rogiers V. Hepatocyte cultures in drug metabolism and toxicological research and testing[J].Methods in Molecular Biology,2006,320:209-227.
7Hsiao G,Lin Y H, Lin CH, et al. The protect effects of PMC against chronic carbon tetrachlofide-induced hepatotoxicity in vivo[J]. Biological pharmaceutical bulletin,2001,24( 11): 1271-1276.
8Yang S F, Tseng J K, Chang Y Y, et al. Flaxseed oil attenuates nonalcoholic fatty liver of hyperlipidemic hamsters[J]. Journal of Agricultural and Food Chemistry,2009,57(11):5078-5083.
9Jin S, Dai C, Yang Y, Sileng A, et al. Effect of hepatic blood inflow occlusion without hemihepatic artery control on apoptosis of liver cells in mts[J].Hepato-gastroenterology,2010,57(97):35-40.
